The Government has brought the control of the new psychoactive substance methiopropamine as a class B drug under the Misuse of Drugs Act 1971 from 27 November 2017

15 December 2017 Posted by

The 1971 Act controls drugs that are ‘dangerous or otherwise harmful’. A three tier system of classification (Class A, B and C) is adopted to provide a framework within which criminal penalties are set. This is based on an assessment of the harms associated with a drug, or its potential harms when misused, and the type of illegal activity undertaken in regards to that drug. The control of MPA has been made following the recommendation of the Advisory Council on the Misuse of Drugs (‘ACMD’).

The National Programme of Substance Abuse Deaths reported 46 cases where MPA was found in post mortem toxicology, between 2012 and April 2017. In all of these occurrences, MPA was found in combination with other substances, mainly NPS. MPA was implicated in the cause of death for 33 cases.

The ACMD recommended that MPA be listed as a Class B drug under the 1971 Act. This drug has also been inserted into Schedule 1 to the 2001 Regulations and designated as a drug to which section 7(4) of the 1971 Act applies since the ACMD reported no known recognised medicinal or legitimate uses beyond potential research use which will be enabled under a Home Office licence.

What is Methiopropamine and what are the risks associated with its use? See Drug Factsheet.

Circular – Changes to the MDA to include MPA – FINAL – DAU


About the Author

Simon, Research & Information Officer, Amethyst, Community Safety Team

Back to top

Safer Cornwall are a working partnership involving: